Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-06

Clinical Trial Update: Safety and Efficacy of a Probiotic Supplement in IBS-D [NA]

View source ↗

Summary

A clinical trial evaluating the safety and efficacy of a probiotic supplement for irritable bowel syndrome with diarrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic supplement

Snippet

Sponsor: The Archer-Daniels-Midland Company | Conditions: Irritable Bowel Syndrome With Diarrhea, Irritable Bowel Syndrome | NA | Status: COMPLETED